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Friedreich’s Ataxia (FRDA) is a neurodegenerative disorder, characterized by
degeneration of dorsal root ganglia, cerebellum and cardiomyopathy. Heart failure is one
of the most common causes of death for FRDA patients. Deficiency of frataxin, a small
mitochondrial protein, is responsible for all clinical and morphological manifestations of
FRDA. The focus of our study was to investigate the unexplored Ca2+ homeostasis
in cerebellar granule neurons (CGNs) and in cardiomyocytes of FRDA cellular models
to understand the pathogenesis of degeneration. Ca2+ homeostasis in neurons and
cardiomyocytes is not only crucial for the cellular wellbeing but more importantly to
generate action potential in both neurons and cardiomyocytes. By challenging Ca2+
homeostasis in CGNs, and in adult and neonatal cardiomyocytes of FRDA models,
we have assessed the impact of frataxin decrease on both neuronal and cardiac
physiopathology. Interestingly, we have found that Ca2+ homeostasis is altered both
cell types. CGNs showed a Ca2+ mishandling under depolarizing conditions and this
was also reflected in the endoplasmic reticulum (ER) content. In cardiomyocytes we
found that the sarcoplasmic reticulum (SR) Ca2+ content was pathologically reduced,
and that mitochondrial Ca2+ uptake was impaired. This phenomenon is due to the
excess of oxidative stress under FRDA like conditions and the consequent aberrant
modulation of key players at the SR/ER and mitochondrial level that usually restore the
Ca2+ homeostasis. Our findings demonstrate that in both neurons and cardiomyocytes
the decreased Ca2+ level within the stores has a comparable detrimental impact in
their physiology. In cardiomyocytes, we found that ryanodine receptors (RyRs) may be
leaking and expel more Ca2+ out from the SR. At the same time mitochondrial uptake
was altered and we found that Vitamin E can restore this defect. Moreover, Vitamin E
protects from cell death induced by hypoxia-reperfusion injury, revealing novel properties
of Vitamin E as potential therapeutic tool for FRDA cardiomyopathy.
Keywords: FRDA, CGNs, cardiomyocytes, calcium, oxidative stress, sarcoplasmic reticulum, ryanodine receptors
and mitochondrial membrane potential
Abbreviations: Ca2+, calcium; CGNs, cerebellar granule neurons; FRDA, Friedreich’s ataxia; ROS, reactive oxygen species;
RyRs, ryanodine receptors; SERCA, sarco/endoplasmic reticulum Ca2+-ATPase; SR, sarcoplasm reticulum.
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INTRODUCTION
Friedreich’s ataxia is caused by frataxin insufficiency leading
to changes in iron metabolism that inhibits mitochondrial
respiration and promotes reactive oxygen species (ROS)
generation, causing mitochondrial dysfunction, oxidative stress
and subsequent mitochondrial iron accumulation (Oudit et al.,
2006). These effects result in selected neuronal atrophy, where
the primary sites of pathology are the dorsal root ganglia (DRG)
(Dyck et al., 1968), and a characteristic proliferation of the
synaptic terminals in the dentate nucleus of the cerebellum
(Koeppen et al., 2007). The neuronal degeneration in DRG seems
to be caused by a dying-back phenomenon triggered by Ca2+
deregulation, including failure to buffer Ca2+ and defective store-
operated calcium entry (SOCE) mechanism (Molla’ et al., 2017).
Ca2+ mishandling has been closely associated to oxidative stress
mediated cell death as Ca2+ chelators proved to be protective
(Wong et al., 1999; Mincheva-Tasheva et al., 2014). CGNs are
also subjected to degeneration, in which we previously showed
increase of oxidative stress and mitochondrial dysfunction in
a FRDA mouse model (Abeti et al., 2016). We have now
investigated whether oxidative stress can be also linked to Ca2+
mishandling in CGNs.
In addition to the pathology of the central and peripheral
nervous system, a hypertrophic cardiomyopathy is commonly
seen at the beginning of the disease, and this progressive
cardiomyopathy is considered one of the most common causes of
death in FRDA (Pastore and Puccio, 2013). Iron-induced
oxidative stress has been associated with altered Ca2+
homeostasis. In particular, it has been associated with reduced
peak systolic Ca2+ levels, slowed rates of Ca2+ relaxation and
elevated diastolic Ca2+ levels in diseases such as hereditary
haemolytic anemia and other iron-overload conditions (Navarro
et al., 2010; Rehsia and Dhalla, 2010), which can lead to
arrhythmias and sudden death, both of which have also been
seen to occur in FRDA. We therefore investigated whether the
lack of frataxin in cardiomyocytes could be relevant to Ca2+
homeostasis, to this purpose we have employed two different
cell lines of cardiomyocytes, one similar to adulthood and one
neonatal and also primary cardiomyocytes from an FRDA mouse
model. The usage of neonatal and adult cardiomyocytes allowed
us to understand whether there could be any differences during
cardiac development in FRDA pathophysiology. Deregulation
of Ca2+ homeostasis has been previously observed in neuronal
models of FRDA (Bolinches-Amoros et al., 2014; Mincheva-
Tasheva et al., 2014), however, this is the first study focused
on Ca2+ signaling in cardiomyocytes of FRDA models. Given
the known association between iron-induced oxidative stress
and altered Ca2+ homeostasis, as well as the overlap with
some pathogenic aspects of FRDA and other neurodegenerative
iron-overload diseases (Isaya, 2014), this study could be of great
benefit in elucidating the pathophysiological mechanism of
FRDA in neuronal and heart cells. The sarcoplasmic reticulum
(SR) is one of the major Ca2+ stores in cardiomyocytes. Ca2+
influx occurs through ryanodine receptors (RyRs Type 2)
operating under a system of Ca2+-induced Ca2+ release (CICR),
where the presence of Ca2+ itself induces further Ca2+ release
from SR stores, generating a Ca2+ wave that contributes to
cardiac action potential (Puccio et al., 2001). Thus, Ca2+ has a
vital role in excitation-contraction coupling in cardiomyocytes.
RyRs together with SR Ca2+ ATPase (SERCA) pumps contain
many free cysteine (Cys) residues that are sensitive to oxidation
(Stephanou et al., 1998; Ying et al., 2008). Oxidative stress may
causes potentiation to RyRs increasing the probability and
the duration of the open state of the RyR channel, which in
turn leads to SR Ca2+ leak (Ying et al., 2008). We therefore
investigated the activity of RyRs and the SR Ca2+ content to
understand whether those could be affected in cardiac FRDA-like
models. Oxidative stress has already been observed in several
models of FRDA (Lamarche et al., 1980; Emond et al., 2000;
Puccio and Koenig, 2000; Bradley et al., 2004; Abeti et al.,
2016). Here, we confirm that oxidative stress is present in CGNs
and cardiomyocytes with a reduced level of frataxin and this
impairs Ca2+ homeostasis. To protect cells from oxidative
stress we have employed Vitamin E, a natural lipid soluble
antioxidant processed in cellular membranes and in particular in
the mitochondria. Previous studies on Vitamin E combined with
Coenzyme Q10 (CoQ10) on FRDA patients showed a beneficial
effect on mitochondrial bioenergetic monitored directly in
the cardiomyocytes and muscle cells with magnetic resonance
spectroscopy (31P-MRS) (Lodi et al., 2001; Hart et al., 2005). At
that time there was not enough natural history on FRDA patients
and cardiomyopathy to have a definitive conclusion of efficacy
(Cooper and Schapira, 2007). We observed the mitochondrial
Ca2+ uptake which improved significantly in frataxin knocked
down cardiomyocytes. Moreover, we have challenged the cells
with hypoxia-reoxigenation (H/R) injury to understand how
cells were coping during H/R damage. The beneficial effect of
Vitamin E improved cell viability in cardiomyocytes stressed
with H/R challenge. Our results confirm that Vitamin E has a
protective effect on FRDA like cardiomyocytes. Therefore, this
compound could be proposed as a therapy for FRDA patients.
MATERIALS AND METHODS
Primary Cultures
Cerebellar granule neurons were obtained from YG8R mice
and their matching control Y47R. YG8R is a humanized mouse
model, which contains a human FXN YAC with 190+82 GAA
repeats on a mouse Fxn null background, that recapitulates the
progressive disease phenotype shown in humans (Al-Mahdawi
et al., 2006; De et al., 2007; Abeti et al., 2016), while Y47R
(Control) has 9 GAA repeats over the same background
(Jackson Laboratory; this study was carried out in accordance
with the recommendations of Animal (Scientific Procedures)
Act 1986 (ASPA). The protocol was approved by the UCL
Animal Welfare and Ethical Review Body (AWERB). CGNs were
isolated with the method described in Abeti et al. (2015, 2016)
with few modifications. In brief, cerebella were isolated and
homogenized and dissociated with 0.25% trypsin-EDTA (Sigma
Aldrich). CGNs were plated on, pre-coated with Poly-D-lysine
(1 mg/ml), glass coverslips. Cells were maintained in Neurobasal
with 2% of B27 (Invitrogen) and 2 mM L-glutamine, 1% of
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penicillin/streptomycin (Sigma Aldrich) and 25 mM KCL (to
keep the CGNs slightly depolarised (Ramay et al., 2010)).
To avoid glial proliferation 10 µM AraC was added after 24 h
from the plating. CGNs were used 7 days after plating. Cells were
maintained in a humidified incubator at 37◦C and at 5% CO2.
Primary cultures of neonatal cardiomyocytes were obtained
from 6 day-old YG8R and Y47R mice (Al-Mahdawi et al., 2006;
De et al., 2007; Abeti et al., 2016). Cardiomyocytes were prepared
with the method described by Stephanou et al., (Schwartz
et al., 2002). Briefly hearts were homogenized and digested with
isolation buffer solution composed (millimolars): 116 NaCl, 20
HEPES, 0.77 NaH2PO, 5.5 D-Glucose, 5.4 KCl, 0.4 MgSO4,
pH adjusted to 7.35. In 100 mL isolation buffer were added:
60 mg collagenase type II CLS2 (∼250 µ/mg, Worthington),
25 mg pancreatin from porcine pancreas (Sigma). After digestion
and cardiomyocytes extraction process the cells were plated in
Dulbecco’s Modified Eagles Medium supplemented with 15%
fetal calf serum and 1% peniccilin /streptomicyn, and maintained
in incubator at 37◦C, 5% CO2.
Cell Cultures
HL-1 (murine adult cells; a generous donation from the lab of
Professor Sean Davidson, Hatter Institute UCL) and H9c2 (rat
neonatal cells; ATCC) were cultured. HL-1 cells were maintained
in Claycomb media (Claycomb et al., 1998) with 10% Fetal
Bovine Serum (FBS; Invitrogen) 100 U/ml penicillin (Sigma
Aldrich), 100 µg/ml streptomycin (Sigma Aldrich), 0.1 mM
norepinephrine and 2 mM L-glutamine. Prior plating flasks were
coated with a solution containing 0.02% gelatin and 5 µg/ml
fibronectin. H9c2 cells were maintained in DMEM with 10%
FBS and 2 mM L-glutamine. Cells were harvested with 0.25%
trypsin-EDTA (Sigma Aldrich), then inactivated with complete
media and plated on 25 mm glass coverslips or directly into a 6
multi-wells plate. All cell lines were maintained in a humidified
incubator at 37◦C and at 5% CO2.
Transfection
To obtain frataxin knock down (FxnKD) cells were tranfected
with Lipofectamine 2000, accordingly to the manufacturer
instruction. Fxn-siRNA was co transfected with YFP-tagged
plasmid (pcDNA3-YFP). Mm_Fxn_1 FlexiTube siRNA was
used as the predesigned siRNA against mouse frataxin
(SI01007139, Qiagen) in HL-1 cells and Rat_Fxn FlexiTube
siRNA (SI02902557, Qiagen) was used in H9c2 cells. Negative
control (Scr) was achieved with AllStars Negative Control siRNA
(1027418, Qiagen) and Rat_Fxn FlexiTube siRNA was used in
H9c2 cells.
Imaging: ROS Measurements
Cells were loaded with dihydroethidium (Het; 5 µM; Thermo
scientific) in HBSS (Sigma), which measures superoxide in the
cytosol. This fluorophore was either used ratiometrically by
exciting the unoxidised form in blue (364 nm) and the oxidized
form in red (543 nm) or by measuring only the oxidized form.
The ratio (543/364 nm) was applied for each cell measurement.
Rates were then calculated. Mitochondrial ROS were measured
with 1 µM CM-H2Xros (Thermo scientific) loaded for 20 min
prior the beginning of the experiments.
Lipid Peroxidation Measurements
To measure lipid peroxidation, cells were loaded with 10 µM
C11 BODIPY (581/591) for 10 min prior the beginning of the
experiments. The dye was excited at 488 nm (oxidized form) and
561 nm (un-oxidized form) (Al-Mahdawi et al., 2006; Abeti et al.,
2015), detected with 710 Zeiss Confocal VIS CLSM equipped with
a META detection system and a 40x oil immersion objective.
The ratio of 488/561 nm was analyzed and the rates were then
calculated in ArbU/minutes.
Calcium Measurements
Transfected cells were loaded with 5 µM Fura-2-AM
(340/380 nm) or 5 µM Fluo4-AM (488 nm) to measure
cytosolic Ca2+ and 5 µM X-Rhod1 AM (562 nm) to measure
mitochondrial Ca2+ levels, in HBSS (Sigma). Dyes were
incubated for 20 min and washed three times prior experiments.
For all the experiments with Thapsigargin HBSS was removed
prior the beginning of the recordings and replaced with a
Ca2+ free saline. Fluorescence measurements were obtained
either using a cooled charge-coupled device (CCD) camera
(Hamamatsu, Orca ER) or 710 Zeiss Confocal system.
Measurement of 19m
Tetramethyl rhodamine, methyl ester (TMRM) is a cationic,
cell-permeant fluorescent dye readily sequestered by healthy
mitochondria. To measure small differences we have used a
quenching mode. Cells were incubated 20 min with 500 nM
TMRM and washed out. 19m depolarization was detected
as an increase in fluorescence (de-quenching). At the end of
each experiment 1 µM Carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone (FCCP) was applied. FCCP is protonophore
that dissipate the potential completely. TMRM was visualized
using an excitation wavelength of 561 nm with a long pass filter
using 710 Zeiss Confocal microscope.
Immunofluorescence
To visualize the FxnKD we have used immunofluorescence
(Abeti et al., 2015). Briefly, cells were fixed with 4% PFA,
permeabilised with 0.5% Triton-X and incubated over night
with an anti-frataxin antibody [17A11] (Abcam, ab113691;
1 µg/ml), and detected with a secondary antibody Alexa Fluor
568 goat anti-mouse (Thermo Fisher Scientific), diluted 1:1000.
Nuclei were detected loading the cells with 300 nM DAPI for
5 min. Images were obtained using a Zeiss 710 LSM equipped
with a META detection system and a 40x oil immersion
objective.
Hypoxia/Reperfusion (H/R) and TUNEL
Assay
After 48 h from transfection the culture media was replaced
with HBSS (Sigma) without glucose and cells placed in a
hypoxic chamber saturated with Argon for 1 h (Hypoxia).
Afterward, 5.5 mM D-glucose was added and cells were kept
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in a humidified incubator at 37◦C and at 5% CO2, for 2 h
(Reoxigenation). 200 µM Vitamin E was added 30 minutes
before the H/R treatment, in the samples indicated. Terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)
assay was performed in order to detect apoptotic cell death
accordingly to the manufacture instructions (Roche).
Statistical Analysis
Statistical analysis was performed with Excel, Origin 9 (Microcal
Software Inc.) and GraphPad5 software (GraphPad Software, La
Jolla, CA, United States). Results are expressed as means ± SEM
or SDM. Mann–Whitney U test and ANOVA tests were
applied when appropriate and the point of minimum acceptable
statistical significance was taken to be 0.05 with Bonferroni
correction. Representative averages were taken from n > 3
independent experiments.
RESULTS
Oxidative Stress in Neurons and
Cardiomyocytes of FRDA Models
It is well established that frataxin decrease causes an elevation
of ROS in many cell types (Pandolfo and Pastore, 2009; Abeti
et al., 2015, 2016; Molla’ et al., 2017). Therefore we first confirmed
that our models of study showed excessive oxidative stress.
CGNs from YG8R mice (FRDA mouse model; see Materials
and Methods) showed a significant increase in mitochondrial
ROS (mROS) generation compared to control cells. Figure 1
shows the loading of the dye (CM-H2Xros) in CGNs and the
kinetic curves and rates generated by Control and YG8R neurons
(Figures 1A–C; YG8R 180 ± 32; ∗p < 0.05). By measuring lipid
peroxidation using C11 BODIPY (581/591), which fluoresces
at two wavelengths (the green fluorescence increases upon
oxidation the red decreases; Figure 1D illustrative figure at 0 min
and at 9 min of the experiment) we performed the ratio and
calculated the rates. This the presence of overall oxidative stress in
this model, as YG8R neurons showed a significant increase in rate
compared to control (Figures 1E,F; Control 0.025± 0.009, YG8R
0.137 ± 0.01; ∗∗∗p < 0.0005). For our study on cardiomyocytes
we choose two cell lines, representative of both adult and juvenile
phenotypes. HL-1 cells (murine adult cardiomyocytes) and H9c2
cells (rat neonatal cardiomyocytes) were co-transfected with
an empty vector expressing YFP and scramble siRNA (Scr)
(as control) or mFxn siRNA to achieve FxnKD. The efficiency
of the FxnKD was assessed via immunocytochemistry and we
found that the level of frataxin was significantly reduced when
compared to control cells (Supplementary Figures S1A–D). To
assess the oxidative stress in our cardiac models, we measured
cytosolic and mROS. By loading the cells with dihydroethidium
FIGURE 1 | Oxidative stress in CGNs of FRDA mouse model. (A) The picture shows the loading of 1 µM CM-H2Xros in CGNs. (B) The graph shows the kinetic
curves normalized, for Control (black) and YG8R (red). (C) The histogram represents the rates of ArbU over minutes in percentage normalized to the Control. mROS
were significantly increased in YG8R CGNs compared to Control (∗p < 0.05). (D) The picture shows CGNs loaded with 10 µM C11 BODIPY (581/591), top left
bright field (bf), at 0 minutes it is shown the oxidized form (top green), the un-oxidized form (top red) and the merge; at 9 min fluorescence it is shown the oxidized
form increased (bottom green), the un-oxidized form decreased (bottom red) and the merge. (E,F) Show respectively the kinetic curves and the rates the lipid
peroxidation (∗∗∗p < 0.0005). Scale bar (20 µm).
Frontiers in Cellular Neuroscience | www.frontiersin.org 4 October 2018 | Volume 12 | Article 264
fncel-12-00264 September 29, 2018 Time: 16:40 # 5
Abeti et al. Ca2+ Homeostasis Deregulation in FRDA
(Het), a fluorophore which becomes fluorescent in red upon
oxidation, sensing ROS within the cell, we measured cytosolic
ROS and found already a significant increase in resting condition
when compared Scr to FxnKD, in HL-1 cells (Figures 2A,B). The
curves in Figure 2A show the ratio of kinetic traces obtained from
recording the blue (un-oxidized) and red (oxidized) fluorescence
over time (see Materials and Methods). The rate of fluorescence
increase calculated over time revealed a significant increment in
FxnKD (Figure 2B; Scr 0.0005 ± 0.0002, FxnKD 0.001 ± 0.0008;
∗p < 0.05). We then detected mROS generation (Figure 2C
shows the loading of the dye and the YFP transfected cells),
using CM-H2Xros. Our data show that FxnKD cells have an
increased level of mROS (Figures 2D,E; FxnKD 207.57 ± 0.79,
∗∗∗p < 0.0001). We have repeated the experiments on H9c2
cells (recording only the oxidative form of Het) and found
similar results. Figures 2F,G show an increase of cytosolic ROS
(Figure 2G; FxnKD 228.8 ± 2.65, ∗p < 0.05). Also mROS were
increased in this model (Figures 2H–J, FxnKD 280.1 ± 118.5,
∗∗p< 0.005). These results demonstrate that by reducing the level
of frataxin expression there is an overall increase of ROS both in
the cytosol and the mitochondria. Having assessed the oxidative
stress in our FRDA-like models we then wondered whether this
could affect Ca2+ homeostasis.
Calcium Mishandeling in FRDA-Like
CGNs
Mitochondrial dysfunction and oxidative stress present in
CGNs of FRDA-like model contribute to neuronal death (Abeti
et al., 2016), and therefore potentially damaging other signaling
pathways within the cells such as Ca2+ homeostasis. By
challenging CGNs with a depolarizing injury we have assessed
the Ca2+ response in control and YG8R. Cells were loaded
with Fluo4-AM (Figure 3A) and challenged with 30 mM KCL
(Figure 3B). The Ca2+ response to high KCL in YG8R CGNs
was higher than the Control and more importantly there was no
recovery to Ca2+ resting levels. The amplitude of this response
was calculated in percentage to control and YG8R cells showed a
significant difference (Figure 3C; YG8R 298± 96, ∗p< 0.05).
During depolarization Ca2+ enters the plasma membrane
increasing the cytosolic levels but then it is quickly sequestered by
the internal stores to restore the Ca2+ homeostasis and neurons
go back to resting condition, ready for the next action potential.
FRDA-like neurons showed an impairment on restore the resting
state and a decreased level of ER Ca2+. Indeed, when YG8R
cells were challenged with Thapsigargin the response was smaller
(Figures 3D,E). The amplitude of the response was much lower
in YG8R than the control (Figure 3E, Control 1.8 ± 0.02, YG8R
0.13 ± 0.07, ∗∗∗p < 0.0005) and also by adding Ca2+ there was a
little response. These results could suggest that the sarcolemmal
ATPase (SERCA) was impaired. Further investigation much be
carried out to verify this possibility.
Impaired Calcium Homeostasis in
FRDA-Like Cardiomyocytes
It is well known that oxidative stress may cause alteration at many
levels in Ca2+ homeostasis (Ermak and Davies, 2002). In order
to understand whether the detected oxidative stress could inflict
aberrant modulation of Ca2+ signaling in cardiomyocytes of
FRDA models, we challenged the cells with 10 mM caffeine, an
agonist of RyRs which elicits Ca2+ from the SR. Any alteration
in SR Ca2+ content or perhaps an inhibition or a potentiation of
the RyRs could be reflected in the intracellular Ca2+ ([Ca2+]i)
response. Cells were loaded with 5 µM Fura2-AM and images
recorded every second. Interestingly the response to caffeine
was remarkably smaller in FxnKD HL-1 cells compared to
control (Figures 4A,B; Control 0.5 ± 0.09, FxnKD 0.2 ± 0.05,
∗∗p < 0.005). This result could indicate that RyRs were
potentiated to extrude more Ca2+ than what was necessary
to restore the Ca2+ homeostasis and/or that SERCA pumps
were not efficiently pumping Ca2+ into the SR. By looking
at the second phase of the Ca2+ response, in HL-1 cells, we
observed that the CICR rhythmic signal was different in the
Scr compared to FxnKD (Figures 4C,D). The frequency and
the amplitude of the signal were higher in FxnKD than the
controls implying a potentiation of the RyRs which then stabilizes
above baseline, reflecting an energetic collapse of the system.
At the same time the decreased amplitude of the caffeine
response could underline a mild impairment at the level of
SERCA pumps. Similarly, the caffeine response was reduced
in transfected H9c2 cells (Figures 4E,F; Control 0.5 ± 0.1,
FxnKD 0.09 ± 0.04); however, there were no signs of oscillatory
events, perhaps due to the different developmental stage. The
detrimental effect of Ca2+ signaling could be explained by the
exacerbation of the oxidative stress in the FRDA like cells,
as RyRs and SERCA have cysteines that are affected by the
variation of the oxidative environment (Stephanou et al., 1998;
Ying et al., 2008). Perhaps both or one of the two calcium
transport systems could be altered. Moreover, a reduction in
SR Ca2+ uptake under pathological heart conditions would be
exacerbated by a leaky Ca2+ release from the SR. For example
it is known that hyperphosphorylation of the RyR2s (the most
prominent isoform in cardiac muscle) increases their probability
of being open (Ying et al., 2008) and also the reduction of
SERCA2a (the most prominent isoform in cardiac muscle)
is strictly correlated to heart failure (Diaz et al., 2005). We
have then tested the content of SR via Thapsigargin (1 µM)
administration, to estimate the level of Ca2+ in the SR. The
[Ca2+]i content elicited by the FxnKD cells was significantly
reduced compared to the controls [Figure 5A loading of Fura
2AM. Figure 5B, Fura2 ratio kinetic curves; Figure 5C, Control
0.7± 0.2, FxnKD 0.2± 0.06, ∗p< 0.05). The decrease of [Ca2+]i
in response to Thapsigargin was also observed in H9c2 cells
(Figures 5D,E; Control 0.8 ± 0.3, FxnKD 0.3 ± 0.1, ∗p < 0.05).
To corroborate our data obtained on cell lines we monitored
[Ca2+]i also in primary cardiomyocytes of YG8R mice. The
results showed yet again a significant decrease in Ca2+ content
of the SR (Figures 5E–G, Control 2.3 ± 0.4, YG8R 0.9 ± 0.18,
∗∗p< 0.005).
By pre-treating cardiomyocytes with 20 µM dantrolene,
an inhibitor of RyRs, we assessed whether the receptors
were already inhibited or not. The results revealed that the
response to Thapsigargin was higher in HL-1 cells pre-treated
with dantrolene than without (Figures 6A,B). In particular
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FIGURE 2 | Frataxin decrease causes oxidative stress in cardiomyocytes. (A,B) HL-1 cells, Scr and FxnKD, were loaded with 10 µM dihydroethydium (Het) and
imaged over time. (A) The kinetic curve show an increase of Het, meaning an increase of cytosolic ROS in FxnKD cells (red). (B) Confirmed by the rate of the dye
(∗p < 0.05). (C) Here it is shown the loading of the dye (red) and the transfected cells (green in the merge). (D,E) The kinetic curves and the histogram represent the
increase of mROS measured with 1 µM CM-H2Xros. Mitochondrial ROS were significantly increased in FxnKD (∗∗∗p < 0.0005). (F,G) We report the results of
cytosolic ROS in H9c2 cells, that also showed a relevant increase in FxnKD (∗p < 0.05). (H–J) Here we report similar mROS measurements in H9c2 cells
(∗∗p < 0.005). Scale bar (20 mm).
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FIGURE 3 | Failure to restore Ca2+ homeostasis after depolarization in YG8R CGNs. (A–C) CGNs were loaded with Fluo4-AM (A) and challenged with 30 mM KCL
(B), amplitudes were measured and showed a higher response in YG8R than Control (C; ∗p < 0.05). (D,E) CGNs response to 1 µM Thapsigargin and 1mM CaCl2,
and relative amplitudes (∗∗∗p < 0.0005). Scale bar (20 µm).
by comparing FxnKD cells untreated and pre-treated with
dantrolene we found a significant increase of [Ca2+]i represented
in the scatter plot showing the amplitude of Thapsigargin
response (Figure 6B; FxnKD 40.7 ± 13.5, Dantrolene_FxnKD
77 ± 7, ∗p < 0.05). These results show that RyR2s were
not inhibited and perhaps activated, causing the decrease
of Ca2+ in the SR, which was restored with dantrolene.
Potentiation of RyR2s causes an excessive release of Ca2+ from
the SR.
Mitochondrial Energy Imbalance Causes
Pathophysiology in FRDA
To investigate the role of mitochondria in this process we
looked at the mitochondrial membrane potential (19m)
during caffeine administration. We found that in both cell
lines the response to caffeine was combined to a depolarization
of 19m in control cells and that was significantly reduced
in FxnKD (Figures 7A–C; B, FxnKD 45.1 ± 0.4, C FxnKD
44 ± 0.36, ∗p < 0.05). This implied that instead of a
physiological mitochondrial Ca2+ [Ca2+]m load, which
can happen when the cytosolic Ca2+ is low, we were
experiencing perhaps a decreased Ca2+ uptake from the
mitochondria.
We then looked at [Ca2+]m after Thapsigargin administration
and found that the mitochondrial re uptake was inefficient and
slower in FxnKD than in controls (Figure 8). By pre-incubating
Vitamin E, as an antioxidant, we found that we could recover
cells with the calcium re-uptake. These results led us to conclude
that the effect of oxidative stress is not only limited to the SR
but also to the MCU uniporter involved in Ca2+ uptake (Dong
et al., 2017). SR Ca2+ store depletion and associated contractile
dysfunction are characteristics of systolic heart failure (HF) that
are thought to be the consequence of depressed SERCA function,
leaky RyRs and increased expression of NCX, mechanisms that
might be implicated in the cellular pathogenesis of FRDA (Ying
et al., 2008).
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FIGURE 4 | FxnKD induces a smaller caffeine response and RyRs potentiation. (A,B) HL-1 cells FxnKD shows a smaller caffeine response compared to Scr cells.
(A) Shows the kinetic of an average of cells and (B) reports the full sets of experiments combined together showing the decreased amplitude in FxnKD cells
(∗∗p < 0.005). (C,D) Highlight phase II of the Ca2+ response in Scr cells and in FxnKD cells. Showing an early end of the Ca2+ response probably ascribed to
energy failure. (E,F) In H9c2 cells the diminished caffeine response in FxnKD was even more marked than HL-1 cells, however, the second phase of Ca2+ response
was flat and the receptors saturated (∗∗p < 0.005).
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FIGURE 5 | Frataxin silencing causes SR Ca2+ store depletion in cardiomyocytes. (A) Loading of Fura2-AM. (B,D,F) FxnKD cells show a marked difference to 1 µM
thapsigargin response compared to Scr. (C–G) The amplitude of the response in relative values % shows a significant decrease in FxnKD cells which reveals a
decrease of Ca2+ content in the SR (∗p < 0.05; ∗∗p < 0.005). Scale bar (20 mm).
To this point we have challenged our cardiomyocytes with
hypoxia reperfusion (H/R) to stress the cells and cause cell
death. By investigating whether the H/R was pushing further the
FRDA compromised phenotype or not we have also wondered
if Vitamin E could protect the cells from apoptosis looking
at TUNEL experiments. The results showed that apoptosis
was increased in FxnKD cells compared to Scr and that
could be prevented by Vitamin E administration (Figure 9,
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FIGURE 6 | Dantrolene prevents SR Ca2+ store depletion in FxnKD cardiomyocytes. (A) HL-1 cells show an increased calcium response after pre-incubation with
dantrolene, an inhibitor of RyRs. (B) Comparing the response between FxnKD and Dantrolene_FxnKD we found a significant increase of the thapsigargin–induced
calcium response in dantrolene pre-treated FxnKD, demonstrating that the RyRs were not inhibited (∗p < 0.05).
FIGURE 7 | FxnKD causes an abnormal energetic response to caffeine in cardiomyocytes. (A) TMRM was loaded in de-quence mode, at high concentration, where
a depolarization of 19m is seen by an increase of fluorescence. The response to caffeine depolarises the potential as the mitochondria are active taking up Ca2+ to
restore the Ca2+ homeostasis of the cell. (B,C) In FxnKD cells the response is reduced revealing that the mitochondria may not take up Ca2+ correctly (∗p < 0.05).
Scale bar (20 µm).
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FIGURE 8 | Mitochondrial Ca2+ is altered during Thapsigargin response.
During Thapsigargin response mitochondrial Ca2+ uptake is reduced in
FxnKD cells. By pre-incubation with Vitamin E the abnormal effect induced by
FxnKD was recovered during the response. However, the decay of the
response was not completely restored.
FIGURE 9 | Vitamin E prevents cell death after hypoxia reperfusion. FxnKD
cardiomyocytes exposed to H/R revealed an enounced vulnerability as the cell
death increased significantly. However, cells pre-treated with Vitamin E
seemed to be protected. The numbers of TUNEL-positive cells were
calculated and the apoptotic cell death was expressed as percentage
(∗∗∗p < 0.0005).
Scr_untr 19.7 ± 41, Scr_H/R 21.6 ± 5, Scr_VitaminE_H/R
16.52 ± 1.6; FxnKD_untr 23.7 ± 13, FxnKD_H/R 76 ± 6,
FxnKD_VitaminE_H/R 29± 6.4; ∗∗∗p< 0.0005).
DISCUSSION
The reduced production of frataxin induces oxidative stress as
a side effect of iron free radicals generation and mitochondrial
energy imbalance (Puccio and Koenig, 2000; Bradley et al., 2004;
Payne, 2011; Abeti et al., 2016). Neuronal and Cardiac tissues
have high energy demand, and as such they are two of the target
tissues where the function of frataxin is relevant (Puccio and
Koenig, 2000). Ca2+ mishandeling in neuronal tissue can affect
the capability to clear up the Ca2+ rise after action potential and
impairing the post synaptic activity. Indeed, during an action
potential Ca2+ rises by entering the cells via Voltage gated Ca2+
channels (VGCCs) and Ligand gated Ca2+ channels (LGCCs)
and/or via its release from the ER. Then Ca2+ should be taken
up by the internal stores and the homeostasis restored. By
challenging CGNs with a depolarising insult, FRDA-like neurons
could not restore their resting potential, leaving the membrane
depolarised until death. This could be ascribed to a possible
hyperactivity of either Inositol trisphosphate receptor (IP3Rs) or
RyRs but also from an inhibition of the SERCA pumps impeding
the Ca2+ to enter the ER and restore its cytosolic homeostasis.
At the same time Ca2+ homeostasis in cardiac myocytes results
from the integrated function of transsarcolemmal influx and
eﬄux pathways modulated by membrane potential and from
intracellular Ca2+ uptake and release predominantly by SR.
Thus, modification of Ca2+ homeostasis may cause significant
alterations in contraction and relaxation of the heart and cardiac
failure (Limbu et al., 2015). Therefore, we focused our studies
on Ca2+ homeostasis in cardiac FRDA like models. We showed
that FxnKD in cardiomyocytes raised the level of ROS in
the cytosol and in the mitochondria. We then demonstrated
that Ca2+ homeostasis was altered, by challenging the cells
with Caffeine and Thapsigargin, as the SR Ca2+ was lower in
FxnKD cells compared to controls. The detrimental effect of
Ca2+ signaling could be explained by the exacerbation of the
oxidative stress in the FRDA like cells, since RyRs and SERCA
present cysteines are affected by the variation of the oxidative
environment (Marx et al., 2000; Diaz et al., 2005). Perhaps both
RyRs and SERCA or one of the two could be altered. A reduction
in Ca2+ content in the SR under pathological heart conditions is
exacerbated by leaky Ca2+ release from the SR. It is known that
hyperphosphorylation of the RyR2 (the predominant isoform in
heart) increases its open probability (Ying et al., 2008) and also
oxidative stress takes place in potentiating the channel. However,
we cannot exclude a SERCA2a (the predominant isoform in
heart) defect in pumping Ca2+ in the SR, as its reduction is
strictly correlated to heart failure (Diaz et al., 2005).
SR Ca2+ store depletion and associated contractile
dysfunction are characteristics of systolic heart failure (HF)
that are thought to be the consequence of depressed SERCA
function, leaky RyRs and increased expression of NCX, and this
could be also the mechanism involved in FRDA (Ying et al.,
2008).
On the other side we have observed that mitochondrial Ca2+
([Ca2+]m) uptake is partially inhibited. This could be due to
the effect of oxidative stress, not only limited to the SR, but
also to the mitochondria and in particular to the mitochondrial
calcium uniporter 1 (MCU) involved in [Ca2+]m uptake (Dong
et al., 2017). This was prevented by Vitamin E administration,
indicating that oxidative stress is one of the major causes of
Ca2+ deregulation in this model. Cells were then challenged with
hypoxia/reperfusion (H/R) to induce cell death, and we have
found that Vitamin E was protective for FxnKD cells. Vitamin E
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has been proposed as possible treatment for FRDA and cardiac
abnormalities several years ago but never followed up due to lack
of natural history on FRDA patients with this secondary effect to
the pathology (Cooper and Schapira, 2007). Vitamin E, together
with a cocktail of other vitamins, was proven to be protective
in chronic HF (Witte et al., 2005). Patients who present with
cardiomyopathy are often treated with bisoprolol to block the
beta adrenergic receptors activated by the sympathetic nervous
system (SNS) (Ramay et al., 2010). In physiological conditions
the SNS is in resting state with no influence on heart function,
but when heart failure occurs it becomes activated to maintain
cardiac function by increasing the ionotropic support (including
Ca2+) and oxidative stress potentiating RyRs (Ramay et al.,
2010). Oxidative stress and RyRs potentiation is exactly what we
have observed in our FRDA models. However, to preserve the
cardiac muscle from oxidative stress and RyRs potentiation, an
antioxidant able to protect the cells from death is needed. Ca2+
homeostasis has been studied in other FRDA cellular models
such as neuronal cell lines and DRG, where the authors found
Ca2+ homeostasis alteration (Bolinches-Amoros et al., 2014;
Mincheva-Tasheva et al., 2014). In cardiomyocytes the RyRs
are more important than others for the SR Ca2+ homeostasis;
those results could indirectly confirm that the major problem of
Ca2+ homeostasis disruption in our cardiac FRDA-like models
is generated by defective RyRs (Bolinches-Amoros et al., 2014;
Mincheva-Tasheva et al., 2014).
CONCLUSION
Our findings have shown a decreased ER/SR Ca2+ content in
FRDA-like neurons and cardiomyocytes. In neurons this could
be due to SERCA pumps inhibition which needs to be further
investigated. Although a similar phenomenon could happen also
in cardiomyocytes, we have proven that there could be a problem
perhaps because of RyRs potentiation bringing out a greater
portion of Ca2+ from the SR. The effect of dantrolene, an
inhibitor of RyRs, proved that the receptors were not inhibited
as the SR Ca2+ was nearly restored. Mitochondrial Ca2+
uptake was found inhibited, similarly to other FRDA-like models
(Bolinches-Amoros et al., 2014) and Vitamin E restored the signal
and prevent from apoptosis induced by H/R. Mitochondrial
dysfunction present in FxnKD cardiomyocytes, was also found
to be strictly related to atrial dilation (Roosimaa et al., 2013) in
other disorders that develop hypertrophic cardiomyopathy. Our
study opens potential trials for cardiomyopathy in FRDA but
also reinforces the need to use antioxidants in conventional HF
where similar mechanisms operate. This work shed a light on how
the modulation of Ca2+ in FRDA-like cardiomyocytes could be
exploited to provide novel therapeutic strategies.
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FIGURE S1 | Frataxin KD in cardiomyocytes. (A) HL-1 cells transfected with Scr
and FxnKD. From top left Scr YFP cells (green), and labeled with Fxn antibody,
showing red fluorescence. Bottom left, DAPI to label the nuclei (blue) and merge.
On the top right panel YFP positive cells in FxnKD and labeled with Fxn antibody,
showing a very low red fluorescence due to the KD. Bottom right, DAPI to label
the nuclei (blue) and merge. (B) The histogram shows the quantification of the Fxn
red fluorescence detected in the dishes and comparing Scr and FxnKD. FxnKD
showed a significant decrease of the Fxn level (∗p < 0.05). Scale bars (20 µm).
(C) H9c2 cells transfected with scr and FxnKD. From top left Scr YFP cells (green),
and labeled with Fxn antibody, showing red fluorescence. Bottom left, DAPI to
label the nuclei (blue) and merge. On the top right panel YFP positive cells in
FxnKD and labeled with Fxn antibody, showing a very low red fluorescence due to
the KD. Bottom right, DAPI to label the nuclei (blue) and merge. (D) The histogram
shows the quantification of the Fxn red fluorescence detected in the dishes and
comparing Scr and FxnKD. FxnKD showed a significant decrease of the Fxn level
(∗∗p < 0.005). Scale bars (20 µm).
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